期刊文献+

人工肝支持系统在肝衰竭中的应用经验和进展 被引量:7

Application experience and progress of artificial liver supporting systems in hepatic failure patients
原文传递
导出
摘要 人工肝支持系统对肝衰竭的治疗作用已经得到公认,可以使部分患者病情得到恢复,还可以使患者有效地过渡到肝脏移植,分为非生物型人工肝、生物型人工肝和混合型3种,包括血浆置换、血液滤过、血液/浆灌流、连续性血液透析滤过、血液透析、白蛋白透析、血浆胆红素吸附和生物型人工肝等。目前常应用的方法有血浆置换、连续性血液透析滤过和血浆胆红素吸附,其作用机制就是通过机械性的方法祛除肝衰竭患者体内的毒性物质及代谢产物,补充部分活性物质,纠正凝血物质缺乏,使患者内环境改善,利于肝细胞再生,病情恢复。 It has been accepted that artificial liver supporting systems have therapeutic effective for hepatic failure. It has the power to make a part of patients recovered from the illness and to get through effective to liver transplantation. It is divided into three kinds, non-bioartificial liver, bioartificial liver and mixed type, including plasma exchange, hemofiltration, hemoperfusion/plasma perfusion, continuous bemodiafiltmtion, hemodialysis, albumin dialysis, plasma bilirubin absorption and bioartificial liver. At present, common application methods are plasma exchange, continuous hemodiafiltration and plasma bilirubin absorption. Its mechanization is that clear the harmful material and products of metabolism, supplement blood active substance and redress coagulation material lacks of the hepatic failure patient. It makes the environmental improvement, for the regeneration of liver cells and recovered from the illness.
出处 《中华临床医师杂志(电子版)》 CAS 2015年第14期7-8,共2页 Chinese Journal of Clinicians(Electronic Edition)
关键词 人工 肝功能衰竭 Liver, artificial Liver failure
  • 相关文献

参考文献4

  • 1中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝支持系统治疗肝衰竭指南[J].中华临床感染病杂志,2009,2(6):321-325.
  • 2于建武,孙丽杰,康鹏,颜炳柱,赵勇华.拉米夫定治疗乙型肝炎急性肝功能衰竭[J].中华传染病杂志,2011,39(1):49-53. 被引量:3
  • 3Ellis AJ, Hughes RD, Wendon JA, et al. Pilot controlled trial of the extraeorporeai fiver assist device in acute liver failure[J]. Hepatology, 1996, 24(6): 1446-1451.
  • 4Flendrig LM, te Velde AA, Chamulean RA. Semipermeable hollow fiber membranes in hepatocyte bioreactors: a prerequisite for a successful bioartifieiai liver[J]. Artif Organs, 1997, 21(11): 1177-1181.

二级参考文献7

  • 1中华医学会感染病学分会肝功能衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝功能衰竭诊疗指南[J].中华传染病杂志,2006,.
  • 2Polson J,Lee WM.American Association for the Study of Liver Disease.AASLD position paper:the management of acute liver failure.Hepatology,2005,41:1179-1197.
  • 3Ostapowicz G,Fontana RJ,Schiφdt FV,et al.Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.Ann Intern Med,2002,137:947-954.
  • 4Miyake Y,Iwasaki Y,Takaki A,et al.Lamivudine treatment improves the prognosis of fulminant hepatitis B.Intern Med,2008,47:1293-1299.
  • 5Tillmann HL,Hadem J,Leifeld L,et al.Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B,a multicenter experience.J Viral Hepat,2006,13:256-263.
  • 6Yu JW,Sun LJ,Zhao YH,et al.Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.J Gastroenterol Hepatol,2008,23:1242-1249.
  • 7Sainokami S,Abe K,Sato A,et al.Initial load of hepatitis B virus (HBV),its changing profile,and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection.J Gastroenterol,2007,42:241-249.

共引文献3

同被引文献67

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部